Concepts (154)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 10 | 2021 | 447 | 3.740 |
Why?
|
| MicroRNAs | 11 | 2024 | 279 | 3.370 |
Why?
|
| Exosomes | 8 | 2021 | 86 | 2.960 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 3 | 2018 | 9 | 1.560 |
Why?
|
| Tumor Microenvironment | 3 | 2021 | 159 | 1.410 |
Why?
|
| Biomarkers, Tumor | 4 | 2019 | 377 | 1.170 |
Why?
|
| Cell Communication | 2 | 2021 | 66 | 1.110 |
Why?
|
| Antineoplastic Agents | 5 | 2024 | 659 | 0.950 |
Why?
|
| Cell Line, Tumor | 18 | 2024 | 1271 | 0.860 |
Why?
|
| Gene Expression Regulation, Neoplastic | 7 | 2019 | 445 | 0.860 |
Why?
|
| Docosahexaenoic Acids | 4 | 2018 | 91 | 0.820 |
Why?
|
| Signal Transduction | 5 | 2019 | 1374 | 0.820 |
Why?
|
| Endometrial Neoplasms | 1 | 2024 | 187 | 0.820 |
Why?
|
| RNA | 2 | 2021 | 106 | 0.710 |
Why?
|
| Repressor Proteins | 2 | 2019 | 114 | 0.670 |
Why?
|
| Histone Deacetylases | 1 | 2019 | 22 | 0.630 |
Why?
|
| Female | 19 | 2024 | 14658 | 0.590 |
Why?
|
| Heme Oxygenase-1 | 6 | 2018 | 36 | 0.500 |
Why?
|
| Humans | 27 | 2024 | 27175 | 0.500 |
Why?
|
| Neoplasms | 4 | 2020 | 769 | 0.480 |
Why?
|
| Mice, Nude | 5 | 2024 | 312 | 0.480 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2015 | 104 | 0.460 |
Why?
|
| Xenograft Model Antitumor Assays | 5 | 2024 | 250 | 0.450 |
Why?
|
| Cell-Derived Microparticles | 1 | 2013 | 10 | 0.430 |
Why?
|
| RNA, Neoplasm | 1 | 2013 | 24 | 0.430 |
Why?
|
| Extracellular Vesicles | 2 | 2024 | 35 | 0.400 |
Why?
|
| Cell Proliferation | 5 | 2024 | 774 | 0.380 |
Why?
|
| Cell Survival | 3 | 2019 | 395 | 0.310 |
Why?
|
| CRISPR-Cas Systems | 2 | 2019 | 43 | 0.310 |
Why?
|
| Animals | 9 | 2024 | 10082 | 0.300 |
Why?
|
| Ovarian Neoplasms | 5 | 2017 | 567 | 0.280 |
Why?
|
| Disulfiram | 2 | 2017 | 4 | 0.270 |
Why?
|
| Disease Progression | 2 | 2018 | 458 | 0.260 |
Why?
|
| Mice | 5 | 2024 | 4472 | 0.240 |
Why?
|
| Neoplasm Invasiveness | 2 | 2018 | 180 | 0.240 |
Why?
|
| Nitrogen Oxides | 1 | 2024 | 40 | 0.230 |
Why?
|
| Protoporphyrins | 2 | 2015 | 11 | 0.230 |
Why?
|
| Interoception | 1 | 2024 | 21 | 0.220 |
Why?
|
| beta Catenin | 2 | 2015 | 62 | 0.220 |
Why?
|
| Paclitaxel | 1 | 2024 | 184 | 0.220 |
Why?
|
| Zinc | 2 | 2014 | 59 | 0.220 |
Why?
|
| Fish Oils | 2 | 2019 | 12 | 0.200 |
Why?
|
| Depressive Disorder, Major | 1 | 2024 | 126 | 0.200 |
Why?
|
| Gene Expression Profiling | 2 | 2016 | 438 | 0.190 |
Why?
|
| Serine-Arginine Splicing Factors | 1 | 2020 | 5 | 0.180 |
Why?
|
| Apoptosis | 3 | 2017 | 738 | 0.170 |
Why?
|
| Inflammation | 1 | 2024 | 605 | 0.170 |
Why?
|
| Case-Control Studies | 2 | 2024 | 708 | 0.160 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2024 | 811 | 0.160 |
Why?
|
| MCF-7 Cells | 1 | 2019 | 34 | 0.160 |
Why?
|
| Gene Knockout Techniques | 1 | 2019 | 35 | 0.160 |
Why?
|
| Gene Ontology | 1 | 2019 | 12 | 0.160 |
Why?
|
| Tamoxifen | 1 | 2019 | 32 | 0.160 |
Why?
|
| Cell Hypoxia | 1 | 2019 | 35 | 0.160 |
Why?
|
| Adenocarcinoma | 1 | 2021 | 287 | 0.160 |
Why?
|
| Green Fluorescent Proteins | 1 | 2019 | 100 | 0.150 |
Why?
|
| NF-E2-Related Factor 2 | 3 | 2014 | 119 | 0.150 |
Why?
|
| Trans-Activators | 1 | 2019 | 114 | 0.150 |
Why?
|
| Middle Aged | 4 | 2024 | 6918 | 0.150 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2018 | 143 | 0.140 |
Why?
|
| Cell Movement | 1 | 2019 | 353 | 0.140 |
Why?
|
| Dietary Supplements | 1 | 2019 | 220 | 0.140 |
Why?
|
| Reproducibility of Results | 2 | 2020 | 752 | 0.140 |
Why?
|
| Aged | 3 | 2021 | 5232 | 0.140 |
Why?
|
| PPAR alpha | 2 | 2013 | 32 | 0.130 |
Why?
|
| Culture Media, Conditioned | 1 | 2016 | 31 | 0.130 |
Why?
|
| Heterografts | 1 | 2016 | 62 | 0.130 |
Why?
|
| Neoplasm Grading | 1 | 2016 | 104 | 0.130 |
Why?
|
| ROC Curve | 1 | 2016 | 137 | 0.130 |
Why?
|
| Prognosis | 1 | 2018 | 762 | 0.130 |
Why?
|
| Aged, 80 and over | 2 | 2021 | 1943 | 0.130 |
Why?
|
| rab27 GTP-Binding Proteins | 1 | 2015 | 5 | 0.120 |
Why?
|
| Pancreatic Neoplasms | 1 | 2021 | 509 | 0.120 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein D | 1 | 2015 | 3 | 0.120 |
Why?
|
| Reactive Oxygen Species | 2 | 2015 | 280 | 0.120 |
Why?
|
| 3' Untranslated Regions | 1 | 2015 | 33 | 0.120 |
Why?
|
| Proteasome Inhibitors | 1 | 2015 | 25 | 0.120 |
Why?
|
| Neoplasm Staging | 1 | 2016 | 463 | 0.120 |
Why?
|
| Biological Transport | 1 | 2015 | 110 | 0.120 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2015 | 33 | 0.120 |
Why?
|
| Proteolysis | 1 | 2015 | 55 | 0.120 |
Why?
|
| Lysosomes | 1 | 2015 | 55 | 0.120 |
Why?
|
| Superoxide Dismutase | 1 | 2015 | 68 | 0.120 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 131 | 0.120 |
Why?
|
| Disease Models, Animal | 2 | 2018 | 1406 | 0.120 |
Why?
|
| Wnt Signaling Pathway | 1 | 2015 | 54 | 0.120 |
Why?
|
| Chloroquine | 1 | 2014 | 9 | 0.120 |
Why?
|
| Enzyme Inhibitors | 1 | 2016 | 247 | 0.120 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2015 | 93 | 0.120 |
Why?
|
| Neovascularization, Physiologic | 1 | 2015 | 123 | 0.110 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2015 | 177 | 0.110 |
Why?
|
| Fanconi Anemia Complementation Group Proteins | 1 | 2014 | 4 | 0.110 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2014 | 31 | 0.110 |
Why?
|
| Clofibrate | 1 | 2013 | 4 | 0.110 |
Why?
|
| Wnt Proteins | 1 | 2013 | 32 | 0.100 |
Why?
|
| Endothelial Cells | 1 | 2015 | 340 | 0.100 |
Why?
|
| Oxidative Stress | 1 | 2017 | 630 | 0.100 |
Why?
|
| Transcription, Genetic | 1 | 2013 | 400 | 0.090 |
Why?
|
| Nonheme Iron Proteins | 1 | 2011 | 2 | 0.090 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2011 | 9 | 0.090 |
Why?
|
| Cadherins | 1 | 2011 | 24 | 0.090 |
Why?
|
| Polycomb Repressive Complex 1 | 1 | 2011 | 34 | 0.090 |
Why?
|
| Prostatic Neoplasms | 1 | 2013 | 271 | 0.090 |
Why?
|
| Nucleotide Motifs | 2 | 2020 | 20 | 0.080 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2011 | 161 | 0.080 |
Why?
|
| RNA, Messenger | 1 | 2011 | 647 | 0.080 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2011 | 280 | 0.080 |
Why?
|
| Promoter Regions, Genetic | 3 | 2014 | 333 | 0.070 |
Why?
|
| Drug Synergism | 2 | 2018 | 100 | 0.070 |
Why?
|
| Blotting, Western | 2 | 2021 | 506 | 0.070 |
Why?
|
| Base Sequence | 2 | 2020 | 575 | 0.060 |
Why?
|
| Genes, Reporter | 2 | 2018 | 88 | 0.060 |
Why?
|
| Adult | 2 | 2024 | 7510 | 0.060 |
Why?
|
| Thiourea | 1 | 2005 | 17 | 0.060 |
Why?
|
| Phenylurea Compounds | 1 | 2005 | 16 | 0.060 |
Why?
|
| Neoplastic Stem Cells | 2 | 2017 | 139 | 0.060 |
Why?
|
| Cell Line | 2 | 2019 | 681 | 0.060 |
Why?
|
| Chromans | 1 | 2005 | 59 | 0.060 |
Why?
|
| Thiones | 1 | 2005 | 55 | 0.060 |
Why?
|
| Mitochondria | 1 | 2007 | 333 | 0.060 |
Why?
|
| Response Elements | 2 | 2013 | 21 | 0.050 |
Why?
|
| Neurons | 1 | 2024 | 274 | 0.050 |
Why?
|
| RNA, Small Interfering | 2 | 2013 | 195 | 0.050 |
Why?
|
| Microscopy, Electron | 1 | 2021 | 94 | 0.050 |
Why?
|
| Circulating MicroRNA | 1 | 2021 | 10 | 0.050 |
Why?
|
| Male | 3 | 2024 | 13034 | 0.040 |
Why?
|
| RNA, Nuclear | 1 | 2019 | 4 | 0.040 |
Why?
|
| Brain | 1 | 2024 | 710 | 0.040 |
Why?
|
| Protein Binding | 1 | 2020 | 636 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2020 | 627 | 0.030 |
Why?
|
| Spheroids, Cellular | 1 | 2017 | 53 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2017 | 310 | 0.030 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2016 | 7 | 0.030 |
Why?
|
| Superoxide Dismutase-1 | 1 | 2015 | 45 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2015 | 80 | 0.030 |
Why?
|
| Protein Transport | 1 | 2015 | 153 | 0.030 |
Why?
|
| Fluorescent Dyes | 1 | 2014 | 88 | 0.030 |
Why?
|
| Antioxidant Response Elements | 1 | 2014 | 5 | 0.030 |
Why?
|
| Lipid Peroxidation | 1 | 2014 | 47 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2015 | 567 | 0.030 |
Why?
|
| Ethylenediamines | 1 | 2013 | 2 | 0.030 |
Why?
|
| Clioquinol | 1 | 2013 | 11 | 0.030 |
Why?
|
| RNA Interference | 1 | 2013 | 135 | 0.030 |
Why?
|
| DNA Primers | 1 | 2013 | 143 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 324 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2013 | 163 | 0.020 |
Why?
|
| Cell Division | 1 | 2007 | 154 | 0.020 |
Why?
|
| Skin Irritancy Tests | 1 | 2005 | 4 | 0.020 |
Why?
|
| Retinoid X Receptors | 1 | 2005 | 24 | 0.020 |
Why?
|
| Alanine Transaminase | 1 | 2005 | 25 | 0.020 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2005 | 32 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2005 | 61 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2005 | 398 | 0.010 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2005 | 285 | 0.010 |
Why?
|